4 ms·
No, we definitely don’t. If the treatment arm is seen as largely effective, the data safety and monitoring board will most definitely recommend unblinding parti
by epmaybe 5y ago
No, we definitely don’t. If the treatment arm is seen as largely effective, the data safety and monitoring board will most definitely recommend unblinding participants and publishing the results as is. Please educate me with trials that do what you say if this is not true.
- pbak 5y agoIf all was well in the land of milk and honey, yes. However, if unlike me, and like most professionals, you didn't spent an unhealthy amount of time researching the details, you wouldn't know they didn't : https://www.bmj.com/content/371/bmj.m4956 https://www.bmj.com/content/371/bmj.m4956 "And even before the FDA advisory committee meeting on Moderna’s vaccine on 17 December, the company notified volunteers that they could learn their status if they chose to receive the vaccine. Pfizer also sent a letter to its trial participants one week after its vaccine was authorised on 10 December." Or you could go the Israeli way, and do the Pharma's job for them, keeping a 290K people with matched control group since December 2020 : https://www.cnbc.com/2021/07/23/delta-variant-pfizer-covid-vaccine-39percent-effective-in-israel-prevents-severe-illness.html https://www.cnbc.com/2021/07/23/delta-variant-pfizer-covid-v... That's what you get when go "warp speed" and doubt anything was done correctly under Trump, to suddenly forget and somehow believe everything was done AOK beforehand now that Biden is in...